The REGAIN clinical trial, the results of which were recently published in Nature Communications (full publication here), is the first clinical trial aiming at the regeneration of cochlear hair cells in patients with mild and moderate sensorineural hearing loss by intratympanic injection…
The session has ended for security reasons.